1 |
Idoko OT, Roberts E, Cox M, Jafali J, Njie-Jobe J, Mackenzie G, et al. Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups. Vaccine 2014;32:4620-4.
DOI
|
2 |
McVernon J, Trotter CL, Slack MP, Ramsay ME. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 2004;329: 655-8.
DOI
|
3 |
Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis 2007;44:810-6.
DOI
|
4 |
Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, et al. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis 2011;17:1645-50.
DOI
|
5 |
Shuel M, Hoang L, Law DK, Tsang R. Invasive Haemophilus influenzae in British Columbia: non-Hib and nontypeable strains causing disease in children and adults. Int J Infect Dis 2011;15:e167-73.
DOI
|
6 |
Kim KH, Lim SY. Validation of enzyme immunoassay for the quantitative measurement of human IgG antibodies specific for Haemophilus influenzae type b capsular poly saccharide. Korean J Pediatr 2007;50:143-50.
DOI
|
7 |
Kim HW, Kim KH, Kim J, Nahm MH. A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b. BMC Infect Dis 2016;16:473.
DOI
|
8 |
Peltola H, Kayhty H, Sivonen A, Makela H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60: 730-7.
|
9 |
Chandran A, Watt JP, Santosham M. Haemophilus influenzae vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia: Elsevier Health Sciences, 2013:167-82.
|
10 |
Pittman M. Variation and type specificity in the bacterial species Hemophilus influenzae. J Exp Med 1931;53:471-92.
DOI
|
11 |
Kim KH, Lee H, Chung EH, Kang JH, Kim JH, Kim JS, et al. Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants. J Korean Med Sci 2008;23:929-36.
DOI
|
12 |
Chalmers C. Necrotising fasciitis complicating Haemophilus influenzae type b epiglottitis in an adult. J Laryngol Otol 2010;124:807-9.
DOI
|
13 |
Oh SY, Griffiths D, John T, Lee YC, Yu LM, McCarthy N, et al. School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis 2008;197:1275-81.
DOI
|
14 |
Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
DOI
|
15 |
Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S, et al. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clin Vaccine Immunol 2012;19:766-71.
DOI
|
16 |
Saito T, Matsunaga H, Matsumura Y, Segawa H, Takakura S, Nagao M, et al. Necrotizing fasciitis caused by Haemophilus influenzae type b in an elderly patient. J Clin Microbiol 2009;47:852-4.
DOI
|
17 |
Chew CG, Clarkson AR, Faull RJ. Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae. Nephrol Dial Transplant 1997;12:821-2.
DOI
|
18 |
Neuhaus TJ, Iselin H, Nadal D. Haemophilus influenzae: a cause of peritonitis in peritoneal dialysis. Nephrol Dial Transplant 1996;11:199-200.
DOI
|
19 |
Public Health Agency of Canada. Canadian immunization guide 2006. 7th ed. Ottawa: Public Health Agency of Canada, 2006.
|
20 |
Collins S, Ramsay M, Campbell H, Slack MP, Ladhani SN. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? Clin Infect Dis 2013;57:1715-21.
DOI
|
21 |
World Health Organization. Guidelines on clinical evaluation of vaccines: regulatory expectations. Proposed revision of WHO TRS 924, Annex 1 [Internet]. Geneva: World Health Organization; 2004 [cited 2017 Nov 7]. Available from: http://www.who.int/biologicals/BS2287_Clinical_guidelines_final_LINE_NOs_20_July_2016.pdf.
|
22 |
Mackenzie GA, Ikumapayi UN, Scott S, Idoko O, Odutola A, Ndiaye M, et al. Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013. Pediatr Infect Dis J 2015;34:e107-12.
DOI
|
23 |
Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009;49:85-92.
DOI
|
24 |
Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005;41:839-47.
DOI
|
25 |
Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI. Comparison of naturally acquired and vaccineinduced antibodies to Haemophilus influenzae type b capsular polysaccharide. Infect Immun 1993;61:5345-50.
|
26 |
Kim YJ, Hwang JY, Choi SH, Kong E, Kim Y, Park KS, et al. Antibody responses in hematopoietic cell transplantation recipients after vaccination against Haemophilus influenzae type b and Streptococcus pneumoniae. Korean J Pediatr Infect Dis 2014;21:81-95.
DOI
|
27 |
Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol 2009;16:376-81.
DOI
|
28 |
Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother 2013;19:412-25.
DOI
|
29 |
Cho HK, Park IH, Burton RL, Kim KH. Impact of IgM antibodies on cross-protection against pneumococcal serogroups 6 and 19 after immunization with 7-valent pneumococcal conjugate vaccine in children. J Korean Med Sci 2016;31:950-6.
DOI
|
30 |
Kim KH. Present status and prospects of Haemophilus influenzae type b (Hib) immunization. Korean J Pediatr 2006;49:242-50.
DOI
|
31 |
Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr 2003;143(6 Suppl):S163-87.
|
32 |
Shinefield HR, Black S. Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. Pediatr Infect Dis J 1995;14:978-81.
DOI
|